These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ. Hucke S; Floßdorf J; Grützke B; Dunay IR; Frenzel K; Jungverdorben J; Linnartz B; Mack M; Peitz M; Brüstle O; Kurts C; Klockgether T; Neumann H; Prinz M; Wiendl H; Knolle P; Klotz L Brain; 2012 May; 135(Pt 5):1586-605. PubMed ID: 22447120 [TBL] [Abstract][Full Text] [Related]
23. Vascular, glial, and lymphatic immune gateways of the central nervous system. Engelhardt B; Carare RO; Bechmann I; Flügel A; Laman JD; Weller RO Acta Neuropathol; 2016 Sep; 132(3):317-38. PubMed ID: 27522506 [TBL] [Abstract][Full Text] [Related]
24. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts). Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976 [TBL] [Abstract][Full Text] [Related]
25. Peripheral immune contributions to the maintenance of central glial activation underlying neuropathic pain. Grace PM; Rolan PE; Hutchinson MR Brain Behav Immun; 2011 Oct; 25(7):1322-32. PubMed ID: 21496480 [TBL] [Abstract][Full Text] [Related]
26. Neuronal regulation of immune responses in the central nervous system. Tian L; Rauvala H; Gahmberg CG Trends Immunol; 2009 Feb; 30(2):91-9. PubMed ID: 19144568 [TBL] [Abstract][Full Text] [Related]
27. Glial cells in neurotoxicity development. Aschner M; Allen JW; Kimelberg HK; LoPachin RM; Streit WJ Annu Rev Pharmacol Toxicol; 1999; 39():151-73. PubMed ID: 10331080 [TBL] [Abstract][Full Text] [Related]
28. Basic aspects of the immunology of neuroinflammation. Wohleb ES; Godbout JP Mod Trends Pharmacopsychiatry; 2013; 28():1-19. PubMed ID: 25224887 [TBL] [Abstract][Full Text] [Related]
29. The role of chronic self-propagating glial responses in neurodegeneration: implications for long-lived survivors of human immunodeficiency virus. Mrak RE; Griffin WS J Neurovirol; 1997 Aug; 3(4):241-6. PubMed ID: 9291232 [TBL] [Abstract][Full Text] [Related]
30. Cytokines in the central nervous system: regulatory roles in neuronal function, cell death and repair. Sei Y; Vitković L; Yokoyama MM Neuroimmunomodulation; 1995; 2(3):121-33. PubMed ID: 8646560 [TBL] [Abstract][Full Text] [Related]
31. Interleukin 15 expression in the CNS: blockade of its activity prevents glial activation after an inflammatory injury. Gómez-Nicola D; Valle-Argos B; Pita-Thomas DW; Nieto-Sampedro M Glia; 2008 Apr; 56(5):494-505. PubMed ID: 18240307 [TBL] [Abstract][Full Text] [Related]
32. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. Ford AL; Goodsall AL; Hickey WF; Sedgwick JD J Immunol; 1995 May; 154(9):4309-21. PubMed ID: 7722289 [TBL] [Abstract][Full Text] [Related]
33. Cytokine and chemokine inter-regulation in the inflamed or injured CNS. Owens T; Babcock AA; Millward JM; Toft-Hansen H Brain Res Brain Res Rev; 2005 Apr; 48(2):178-84. PubMed ID: 15850656 [TBL] [Abstract][Full Text] [Related]
34. Production of interleukin-10 by mouse glial cells in culture. Mizuno T; Sawada M; Marunouchi T; Suzumura A Biochem Biophys Res Commun; 1994 Dec; 205(3):1907-15. PubMed ID: 7811281 [TBL] [Abstract][Full Text] [Related]
35. Anti-inflammatory effect by lentiviral-mediated overexpression of IL-10 or IL-1 receptor antagonist in rat glial cells and macrophages. van Strien ME; Mercier D; Drukarch B; Brevé JJ; Poole S; Binnekade R; Bol JG; Blits B; Verhaagen J; van Dam AM Gene Ther; 2010 May; 17(5):662-71. PubMed ID: 20182518 [TBL] [Abstract][Full Text] [Related]
36. Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice. Huang D; Wujek J; Kidd G; He TT; Cardona A; Sasse ME; Stein EJ; Kish J; Tani M; Charo IF; Proudfoot AE; Rollins BJ; Handel T; Ransohoff RM FASEB J; 2005 May; 19(7):761-72. PubMed ID: 15857890 [TBL] [Abstract][Full Text] [Related]
37. DAB389IL-2 suppresses autoimmune inflammation in the CNS and inhibits T cell-mediated lysis of glial target cells. Bhopale MK; Hilliard B; Constantinescu CS; Fujioka T; Ventura E; Phillips SM; Rostami A Exp Mol Pathol; 2014 Feb; 96(1):108-17. PubMed ID: 23872438 [TBL] [Abstract][Full Text] [Related]
38. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis. Krakowski ML; Owens T Eur J Immunol; 1997 Nov; 27(11):2840-7. PubMed ID: 9394808 [TBL] [Abstract][Full Text] [Related]
39. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Tyor WR; Glass JD; Griffin JW; Becker PS; McArthur JC; Bezman L; Griffin DE Ann Neurol; 1992 Apr; 31(4):349-60. PubMed ID: 1586135 [TBL] [Abstract][Full Text] [Related]
40. Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination. Brambilla R; Morton PD; Ashbaugh JJ; Karmally S; Lambertsen KL; Bethea JR Glia; 2014 Mar; 62(3):452-67. PubMed ID: 24357067 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]